Foxo Technologies Investor Relations Material

Foxo Technologies Inc. is a biotechnology company focused on using epigenetic science and artificial intelligence to develop advanced health and longevity solutions. The company integrates molecular biotechnology with data analytics to offer innovative products in the life insurance and health sectors. Foxo's platform is designed to leverage epigenetic biomarkers to assess biological aging and health risks, aiming to transform underwriting processes in the life insurance industry. The company’s work in epigenetics seeks to provide more personalized insights into health and wellness. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NYSE.